Table 1.
Total | |
---|---|
Median age [months] | 3 (0–6) |
Origin [n = 100] | |
Germany/Austria/Switzerland | 74 |
Other countries | 26 |
Sex [n = 100] | |
Female | 49 |
Male | 51 |
Localization [n = 117] * | |
Intracranial MRT (ATRT) | 62 |
Cerebellum | 35 |
Cerebral hemisphere | 9 |
Lateral, 3rd, 4th ventricle | 8 |
Pineal gland | 4 |
Brain stem | 4 |
Basal ganglia | 2 |
Extracranial MRT | 55 |
Kidney | 15 |
Liver | 7 |
Neck | 6 |
Orbit | 4 |
Thorax | 3 |
Skin | 3 |
Retroperitoneum | 2 |
Pelvic soft tissue | 2 |
Cheeks | 2 |
Pre-auricular | 1 |
Clavicle | 1 |
Heart | 1 |
Pancreas | 1 |
Abdomen | 1 |
Adrenal gland | 1 |
Arm | 1 |
Hand | 1 |
Thigh | 1 |
Sacrum | 1 |
Scrotum | 1 |
Metastasis [n = 97] ** | |
M0, LN− | 49 |
M0, LN+ | 5 |
M+ | 26 |
Synchronous tumor | 17 |
* Anatomical localization of 100 patients, including patients with synchronous tumors (n = 17). ** Metastatic stage (M-stage) in n = 3 patients not available, M0, LN−; localized disease without loco-regional lymph node involvement, M0, LN+; localized disease with loco-regional lymph node involvement, M+; metastasis.